PH12014501796A1 - Methods and composition related to brown adipose-like cells - Google Patents

Methods and composition related to brown adipose-like cells

Info

Publication number
PH12014501796A1
PH12014501796A1 PH12014501796A PH12014501796A PH12014501796A1 PH 12014501796 A1 PH12014501796 A1 PH 12014501796A1 PH 12014501796 A PH12014501796 A PH 12014501796A PH 12014501796 A PH12014501796 A PH 12014501796A PH 12014501796 A1 PH12014501796 A1 PH 12014501796A1
Authority
PH
Philippines
Prior art keywords
cells
brown adipose
artery
derived
methods
Prior art date
Application number
PH12014501796A
Other languages
English (en)
Inventor
Seyda Agnieszka
David C Colter
Charito S Buensuceso
Christian C Kazanecki
Dhanaraj Sridevi
Original Assignee
Depuy Synthes Products Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Depuy Synthes Products Llc filed Critical Depuy Synthes Products Llc
Publication of PH12014501796A1 publication Critical patent/PH12014501796A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653Adipocytes; Adipose tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PH12014501796A 2012-02-15 2014-08-08 Methods and composition related to brown adipose-like cells PH12014501796A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261599080P 2012-02-15 2012-02-15
PCT/US2013/026170 WO2013123214A1 (en) 2012-02-15 2013-02-14 Methods and composition related to brown adipose-like cells

Publications (1)

Publication Number Publication Date
PH12014501796A1 true PH12014501796A1 (en) 2014-11-24

Family

ID=47757703

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12014501796A PH12014501796A1 (en) 2012-02-15 2014-08-08 Methods and composition related to brown adipose-like cells

Country Status (16)

Country Link
US (1) US20130209418A1 (https=)
EP (1) EP2814949A1 (https=)
JP (1) JP2015508654A (https=)
KR (1) KR20140133574A (https=)
CN (1) CN104114693A (https=)
AU (1) AU2013221474A1 (https=)
BR (1) BR112014020229A8 (https=)
CA (1) CA2864103A1 (https=)
HK (1) HK1205185A1 (https=)
IN (1) IN2014DN06603A (https=)
MX (1) MX2014009837A (https=)
PH (1) PH12014501796A1 (https=)
RU (1) RU2014137102A (https=)
SG (1) SG11201404763XA (https=)
WO (1) WO2013123214A1 (https=)
ZA (1) ZA201406726B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10335437B2 (en) 2012-08-10 2019-07-02 The Trustees Of Columbia University In The City Of New York Injectable brown adipose microtissues for treatment and prevention of obesity and diabetes
AU2014253920B2 (en) * 2013-04-19 2019-07-04 Biorestorative Therapies, Inc. Human brown adipose derived stem cells and uses
WO2014197421A1 (en) 2013-06-05 2014-12-11 Biotime, Inc. Compositions and methods for induced tissue regeneration in mammalian species
US10092738B2 (en) * 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
WO2017009263A1 (en) * 2015-07-10 2017-01-19 Etablissement Francais Du Sang Method for obtaining human brown/beige adipocytes
CA3202332A1 (en) 2015-12-07 2017-06-15 Agex Therapeutics, Inc. Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells
US20210077536A1 (en) 2019-04-29 2021-03-18 Biorestorative Therapies, Inc. Non-naturally occuring three-dimensional (3d) brown adipose-derived stem cell aggregates, and methods of generating and using the same
CN110484566B (zh) * 2019-08-29 2021-06-29 中国人民解放军第四军医大学 一种类棕色脂肪外泌体及其工程化生产方法和应用
WO2021106698A1 (ja) * 2019-11-25 2021-06-03 株式会社片岡製作所 培地用組成物
CN113493764B (zh) * 2021-07-27 2023-01-24 新乡医学院 一种体外诱导小鼠耳朵间充质干细胞分化为脂肪细胞的方法
CN114225006B (zh) * 2021-12-22 2023-10-13 南京市妇幼保健院 一种棕色脂肪细胞分泌肽在低体温疾病防治中的应用
WO2025153091A1 (en) * 2024-01-19 2025-07-24 China Medical University Genetically engineered mesenchymal stem cells and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100150885A1 (en) * 2005-06-01 2010-06-17 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
CN102083969A (zh) * 2008-05-06 2011-06-01 乔斯林糖尿病中心股份有限公司 诱导褐色脂肪形成的方法和组合物
JP6078228B2 (ja) * 2008-05-27 2017-02-08 オリバー ディー. ボス, ヒト骨格筋における褐色脂肪細胞前駆体
US8323972B2 (en) * 2009-09-30 2012-12-04 Advanced Technologies And Regenerative Medicine, Llc Mammary artery derived cells and methods of use in tissue repair and regeneration

Also Published As

Publication number Publication date
BR112014020229A8 (pt) 2017-07-11
AU2013221474A1 (en) 2014-09-25
HK1205185A1 (en) 2015-12-11
MX2014009837A (es) 2014-09-16
EP2814949A1 (en) 2014-12-24
CN104114693A (zh) 2014-10-22
SG11201404763XA (en) 2014-10-30
IN2014DN06603A (https=) 2015-05-22
BR112014020229A2 (https=) 2017-06-20
ZA201406726B (en) 2016-05-25
US20130209418A1 (en) 2013-08-15
WO2013123214A1 (en) 2013-08-22
JP2015508654A (ja) 2015-03-23
RU2014137102A (ru) 2016-04-10
CA2864103A1 (en) 2013-08-22
KR20140133574A (ko) 2014-11-19

Similar Documents

Publication Publication Date Title
PH12014501796A1 (en) Methods and composition related to brown adipose-like cells
ZA202106265B (en) Compositions and methods for inhibiting gene expression of lpa
NZ599830A (en) Novel kinase modulators
MY160349A (en) Pyridone and aza-pyridone compounds and methods of use
EP2555627A4 (en) METHOD FOR TREATING CARCINOMA
WO2012058673A3 (en) Enhanced cancer treatment and monitoring using recombinant vectors
PH12013500389A1 (en) Differentiation of human embryonic stem cells
WO2012000103A8 (en) Methods of targeting pten mutant diseases and compositions therefor
MX2014005282A (es) Compuestos de 8-fluoroftalazin-1 (2h) -ona.
MX2015000428A (es) Composiciones y metodos para regular celulas t car.
NZ608734A (en) Bone marrow derived cd271 precursor cells for cardiac repair
MX2014005285A (es) Compuestos biciclicos de piperazina.
HK1203552A1 (en) Differentiation of human embryonic stem cells into single hormonal insulin positive cells
PH12014500966A1 (en) Alkylated piperazine compounds as inhibitors of btk activity
MX421064B (es) Composiciones de nanoparticulas lipidicas y metodos para administracion de arnm
MX2014005331A (es) Compuestos de heteroaril piridona y aza-piridona.
PH12013500367A1 (en) Differentiation of human embryonic stem cells
MX343931B (es) Tratamiento de la esclerosis lateral amiotrofica con el uso de celulas derivadas del cordon umbilical.
WO2013149211A3 (en) Compositions and treatment methods for mesenchymal stem cell-induced immunoregulation
WO2012092049A3 (en) Brown adipocyte modification
MX2019007057A (es) Composiciones de adenovirus.
WO2013124815A3 (en) Mesenchymal stem cells for in vitro modeling and cell-based therapy of human diseases and banks thereof
HK1197276A1 (en) Methods and compositions for the treatment and diagnosis of bladder cancer
NZ741724A (en) Renal cell populations and uses thereof
EP2703481A4 (en) BROWN ADIPOCYTES OBTAINED FROM PLURIPOTENTIAL STEM CELLS, CELL AGGRAIN OBTAINED FROM PLURIPOTENTIAL STEM CELLS, METHOD OF MANUFACTURE THEREOF, AND CELL THERAPY AND MEDICAL THERAPY THEREFOR